Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
GNOMvsIBBETF Comparison
Global X Genomics & Biotechnology ETF - USD (GNOM) belongs to the BioTech & Genomics segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.44% for IBB. GNOM is down -0.99% year-to-date (YTD) with -$2M in YTD flows. IBB performs better with 1.32% YTD performance, and -$114M in YTD flows. Run a side-by-side ETF comparison of GNOM and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
GNOM vs IBB performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM IBB | -2.35%-1.01% | -3.29%+0.56% | -0.99%+1.32% | +29.80%+27.96% | -6.02%+37.52% | -51.80%+11.22% |
| Flows | GNOM IBB | -+$211M | -$4M-$360M | -$2M-$114M | -$19M+$659M | -$115M-$1.65B | +$11M-$2.40B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM IBB | +23.45%+20.19% | +30.08%+23.43% | +28.53%+19.45% | +33.47%+22.09% |
| Max drawdown | GNOM IBB | -10.89%-5.59% | -22.14%-17.66% | -46.50%-24.82% | -72.17%-39.75% |
| Max drawdown duration | GNOM IBB | 48d48d | 113d148d | 1031d377d | 1714d1611d |
GNOM | IBB | |
Last sale 3/11/2026 at 1:30 PM | $45.00 | $170.87 |
| Previous close 03/11/2026 | $45.33 | $172.27 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GNOM | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GNOM | IBB | |
|---|---|---|
| Last price | $45.00 | $170.87 |
| 1D performance | -0.74% | -0.81% |
| AuM | $49.36 M | $8.34 B |
| E/R | 0.5% | 0.44% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the GNOM and IBB ETFs performed in 2026?
As of March 11, 2026, GNOM is down -0.99% year-to-date (YTD), while IBB has returned 1.32%. That puts IBB better performer ahead so far this year.
Which ETF is attracting more investor money: GNOM or IBB?
Year-to-date, the GNOM ETF saw -$2M in flows, compared to -$114M for IBB.
Which ETF is more volatile: GNOM or IBB?
Over the past year, GNOM had a volatility of 30.08%, while IBB experienced 23.43%.
Which ETF is bigger: GNOM or IBB?
As of March 11, 2026, GNOM holds $49.36 M in assets under management (AUM), while IBB manages $8.34 B.
What sectors do the GNOM and IBB ETFs invest in?
GNOM leans toward sectors like Health Care. Meanwhile, IBB focuses on Health Care.
What are the top holdings of the GNOM ETF and IBB ETF?
GNOM top holdings include MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070. IBB holds in its top three: GILEAD SCIENCES, VERTEX PHARMACEUTICALS and AMGEN-T.
Which ETF is more diversified: GNOM or IBB?
GNOM holds 48 securities with 63.95% of its assets in the top 15. IBB has 254 securities and a top 15 weight of 56.67%.
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
Are Biotechnology ETFs In the Midst of a Comeback?
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
Health is Wealth: A look at the Healthcare Sector
Biotech ETFs – Investing in Health Innovation
Biotech ETFs – Investing in Health Innovation
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
